Skip to main content
logo
Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
Inactive · Last trade price on Aug 31, 2026

Crinetics Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9,0104,4174,7422,3779851,340
Market Cap Growth
208.73%-6.84%99.50%141.36%-26.50%188.40%
Enterprise Value
7,8523,3743,9321,8746201,151
Last Close Price
84.9546.5551.1335.5818.3028.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
213.74573.964563.69592.26207.881242.80
PB Ratio
7.544.453.584.413.114.04
P/TBV Ratio
7.564.453.584.413.114.04

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
186.25438.423783.97467.04130.821067.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.050.040.100.010.01
Net Debt / Equity Ratio
-0.97-0.99-0.98-0.94-1.05-0.99
Net Debt / EBITDA Ratio
2.131.913.882.291.993.09
Net Debt / FCF Ratio
2.732.555.572.932.843.70
Asset Turnover
0.030.010.000.010.010.00
Quick Ratio
15.2412.0922.6912.9212.1720.96
Current Ratio
15.5712.3223.0513.0712.4521.55
Return on Equity (ROE)
-42.45%-40.17%-32.02%-50.16%-50.57%-42.98%
Return on Assets (ROA)
-26.28%-25.22%-20.46%-28.18%-29.84%-25.19%
Return on Capital Employed (ROCE)
-44.20%-49.60%-24.60%-37.60%-51.70%-32.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.57%-10.53%-6.29%-9.03%-16.65%-8.04%
FCF Yield
-4.72%-8.69%-4.94%-7.29%-11.87%-6.64%
Buyback Yield / Dilution
-11.25%-16.43%-39.11%-11.71%-35.24%-26.24%
SEC Filings: 10-K · 10-Q